University of California, San Francisco – Neuroblastoma

Submitted By:

Published Date:

January 25, 2020

This is a compassionate use protocol to allow patients with advanced neuroblastoma
palliative access to 131I-metaiodobenzylguanidine (131I-MIBG).

Rare Disease:

Neuroblastoma